Showing 1 - 10 of 202
up the efficiency issue of implementing TRIPS and at the same time allowing international exhaustion of patent rights. …
Persistent link: https://www.econbiz.de/10011115487
is given to the role of article 27 of the Trade Related Intellectual Property Rights (TRIPS) agreement as well as the …
Persistent link: https://www.econbiz.de/10011259795
monopolistic manufacturer of pharmaceuticals and a foreign exclusive distributor we, first, show that parallel trade reduces the …
Persistent link: https://www.econbiz.de/10011107968
products, be they pharmaceuticals or software. The purpose of this review is to help understand the current discourse on …
Persistent link: https://www.econbiz.de/10011259757
, and the activities of Shaman Pharmaceuticals in Latin America and Africa. It provides the details, discusses what each …
Persistent link: https://www.econbiz.de/10005621738
their national IPR regimes to conform to the TRIPs requirements. IPRs tend to raise income inequality by generating a more …
Persistent link: https://www.econbiz.de/10011111782
This thesis deals with the influence of the international regime of intellectual property established by the Marrakesh Agreement (WTO) in 1995 on the world economy and more specifically on the 2007-2008 financial crisis. The establishment of a patent was first granted in the fifteenth century by...
Persistent link: https://www.econbiz.de/10008805883
What are the effects of the WTO's TRIPS Agreement on growth, welfare and income inequality? To analyze this question …, we develop an open-economy R&D-driven endogenous-growth model with wealth heterogeneity. Under TRIPS, the North … importance of foreign goods below which global welfare decreases under TRIPS. In light of our findings, we discuss policy …
Persistent link: https://www.econbiz.de/10005617038
Small firms dominate the Indian pharmaceutical industry with significant contribution to the national drug production and employment. They had played an important role in enhancing domestic technological capabilities in drugs production and have been instrumental in keeping drugs prices...
Persistent link: https://www.econbiz.de/10005622178
This study assesses the market structure and competitiveness of Malaysian pharmaceutical industry. A panel analysis of 41 pharmaceutical manufacturing firms over 2004-2012 is conducted founded on the modified Structure-Conduct-Performance (SCP) framework. Our study reveals that the Malaysian...
Persistent link: https://www.econbiz.de/10011107532